Rijnstate

Running trials

• Not yet recruiting

  A Physical Activity Programme Focussed on Step Volume and Intensity for People With Cardiovascular Disease: Getting Active and Staying Active After Cardiac Rehabilitation

  NCT07723274· Source

• Recruiting

  Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)

  NCT07582458· Phase 2/3· Source

• Recruiting

  Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma

  NCT07680556· Source

• Recruiting

  Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

  NCT07556887· Source

• Recruiting

  Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure

  NCT07070583· Source

• Recruiting

  Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation

  NCT07200466· Source

• Recruiting

  OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes

  NCT06476119· Source

• Recruiting

  Spinal Cord Monitoring in Multiple Sclerosis

  NCT06827834· Source

• Active, not recruiting

  Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage

  NCT05986968· Source

• Recruiting

  Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients

  NCT05701241· Phase 4· Source

• Recruiting

  COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

  NCT05301881· Phase 2· Source

• Recruiting

  National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)

  NCT05326620· Source

• Recruiting

  Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy

  NCT04833426· Phase 3· Source

• Active, not recruiting

  SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)

  NCT05392608· Phase 2· Source

• Active, not recruiting

  Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)

  NCT04597671· Phase 3· Source

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Source

• Recruiting

  Prospective Bladder Cancer Infrastructure (ProBCI)

  NCT04503577· Source

• Recruiting

  Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

  NCT06434896· Source

• Active, not recruiting

  Multicentric Randomised Trial for Resectable Gastric Cancer

  NCT02931890· Phase 2· Source

• Active, not recruiting

  Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

  NCT03425838· Phase 3· Source

• Active, not recruiting

  Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

  NCT02284308· Source

• Recruiting

  Prospective Data Collection Initiative on Colorectal Cancer

  NCT02070146· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer2 recruiting
• Kidney cancer2 recruiting
• Bladder cancer1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Endometrial cancer1 recruiting
• High blood pressure1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple sclerosis1 recruiting
• Neuroendocrine tumours1 recruiting
• Prostate cancer1 recruiting
• Stroke1 recruiting
• Triple-negative breast cancer1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Dietary Fiber Before Colorectal Cancer Surgery

  NCT06212817· Source

• Completed

  The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis

  NCT07840924· Phase 2· Source

• Completed

  Dual Hormone Closed Loop in Type 1 Diabetes

  NCT05669547· Source

• Completed

  SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes

  NCT04889183· Phase 3· Source